Q1. What is one FDA-approved drug, one off-label drug, and one nonpharmacological intervention used in older adults to treat Schizophrenia?
Q2. What risk assessment tool may be used to inform the treatment decision-making?
Q3. What are the risks and benefits of the FDA-approved medicine?
Q4. What are the risks and benefits of the off-label drug?
Q5. What clinical practice guidelines exist for Schizophrenia? and how do they justify the recommendations listed?